NOTICE
Our Presentation
Beneficial effect on intestinal growth of a long-acting GLP-2 analog, HM15912, after treatment switching from conventional GLP-2 drug or other long-acting GLP-2 analogs under clinical development in animal model
Abstract Number: SAT-028
Session: P59 - Membrane Receptors and Intracellular Signaling: Membrane Receptor Signaling, June 17, 2023, 1:00 PM - 2:00 PM CST, ENDOExpo
Presenter: In Young Choi, Ph.D. / Hanmi Pharmaceutical
HM15912, a novel long-acting GLP-2 analog, improves intestinal growth and absorption capacity in rat model of short bowel syndrome
Abstract Number: SAT-030
Session: P59 - Membrane Receptors and Intracellular Signaling: Membrane Receptor Signaling, June 17, 2023, 1:00 PM - 2:00 PM CST, ENDOExpo
Presenter: Jaehyuk Choi, Ph.D. / Hanmi Pharmaceutical
In vitro characterization of a novel long-acting glucagon analog (HM15136) and its potential effect in animal models of chronic hypoglycemic diseases
Abstract Number: SAT-149
Session: P65 - Diabetes & Vascular Disease: Hypoglycemia, June 17, 2023, 1:00 PM - 2:00 PM CST, ENDOExpo
Presenter: Jung Kuk Kim, Ph.D. / Hanmi Pharmaceutical